A prospective study of 94 patients undergoing elective lower segment caesarean section under epidural anaesthesia was performed in order to determine the incidence of shivering and the influence of epidural pethidine. Epidural anaesthesia was established with bupivacaine 0.5% with adrenaline, with or without additional lignocaine 2% with adrenaline, to total 20-25 ml. With the injection of epidural local anaesthesia an extra 5 ml of solution was administered into the epidural space -pethidine 25 mg preservative-free, in normal saline, or normal saline alone. Patient, administering anaesthetist and observer were blinded to the nature of the test substance. Shivering was assessed by an independent observer and subsequently rated by the patient. Other side-effects also recorded were nausea, vomiting, pruritis and drowsiness. The incidence of shivering was 36% in the control (saline) group and 11% in the pethidine group. The difference was highly significant (P < 0.01). There was no significant difference in the incidence of maternal nausea, vomiting, drowsiness or pruritis, or neonatal Apgar scores. Cord blood samples were assayed for pethidine, revealing low or absent pethidine concentrations.
The problem of shivering related to epidural blockade both during labour and for caesarean section has long interested and perplexed clinicians. Theories abound as to the aetiology of this shivering. No single fully effective remedy has yet been demonstrated. Some authors have estimated the incidence of shivering associated with epidural blockade as high as 50%, I and in one large series, women in labour reported shivering related to epidural anaesthesia to be the single most distressing symptom. 2 In our institution the incidence of shivering associated with epidural anaesthesia for elective lower segment caesarean section had been found in previous surveys to be in excess of 30%. Shivering may produce an increased physiological demand on the mother, necessitating an increase in minute ventilation and cardiac output to match an increase in oxygen requirement.
In theory at least, shivering may stress the mother and fetus. It may also interfere with monitoring. It may be disturbing to the patient and her partner who expect caesarean section under epidural anaesthesia to be a safe and satisfying experience.
Our interest in this area was stimulated by a publication in this Journal in November 1986. 3 Brownridge showed that 25 mg of pethidine administered via the epidural space was effective in reducing or, in many cases, abolishing the shivering associated with epidural analgesia during labour. In his article he states that epidural pethidine 'might be useful also to control shivering which occurs so commonly during epidural caesarean section, although this remains to be confirmed'.
MATERIALS AND METHODS The trial was approved by the Hospital Medical Ethics Review Committee. Informed patient consent was obtained. One hundred patients undergoing elective lower segment caesarean section under epidural anaesthesia were to be entered into the trial. Patients with known pethidine hypersensitivity, opioid addiction, renal disease or severe pregnancy associated hypertension were excluded from the trial.
After an intravenous pre-Ioad of 1000-1500 ml of Hartmann's solution, epidural anaesthesia was established with bupivacaine 0.5% with adrenaline 1 :200,000 with or without lignocaine 2% with adrenaline 1 :200,000, to total 20-25 m!. Both intravenous fluids and epidural agents were administered at room temperature. In addition, 5 ml of solution was injected via the epidural catheter. This solution contained either pethidine 25 mg preservative-free in saline, or saline alone. One hundred coded ampoules had been prepared for this purpose with random distribution between pethidine and saline groups, and the code kept from the investigators by an administrative assistant. We requested that anaesthetists use no premedication or any supplementary intravenous opioid or sedative agent prior to delivery. Shivering was assessed by an independent observer present at delivery -either paediatrician or neonatal unit nurse. Observation of shivering took place after delivery, over a period often minutes, at the time of initial mother-child bonding. Neonatal Apgar scores at 1 and 5 minutes were recorded. Cord blood was sampled at delivery from all patients. Subsequently, cord blood from the pethidinetreated group was analysed, once the code was broken. Patient follow-up determined the patients' assessment of shivering (severe or not severe), and degree of distress. Patients were also questioned about symptoms which might be attributable to epidural pethidine -nausea, vomiting, drowsiness, pruritis. Patients were monitored in the recovery ward for four hours for signs of early respiratory depression. Subsequent parenteral analgesia was given on demand.
A Chi-squared test or Fisher exact test was used to assess differences between treatment (pethidine) and control groups in incidence of shivering and its severity, and incidence of side-effects. Apgar scores at 1 and 5 minutes were compared using Wi1coxon Rank tests. Cord blood was assayed for pethidine using a solvent extraction technique, followed by gas-liquid chromatography with nitrogen selective detection.
RESULTS
Ninety-four patients were entered into the study. Six of the coded ampoules were broken during storage. Treatment and control groups were statistically similar in terms of age, weight, temperature and volume of local anaesthetic agent used. The level of sensory blockade in all cases was T4-T6, providing adequate conditions for surgery. Results are presented in Tables 1, 2 using a Chi-squared test resulted in a value for Chisquared of 8.55 with one degree of freedom (P = 0.003) -a highly significant difference between the groups ( Table 1 ). The patients' own subjective assessment of shivering differed from that of the independent observer. An additional eleven patients felt that shivering had occurred, making a total of 33 'subjective shiverers'. Results are presente.d. in Table 2 . Eleven shiverers came from the pethldme group, and 22 from the saline group. C~i-s<:tuared analysis of this data revealed a slgmficant reduction in subjective shivering (Chi-squared 7.89, P = 0.005).
By blind objective observation, shivering occurred in 22 patients, and in six of these patients shivering was rated as severe. These six patients subsequently stated that severe shivering had significantly marred their experience of childbirth. Five of these patients came from the control (saline) group and one from the treatment (pethidine) group. This difference was not significant using a Fisher exact test (Table 3) .
Seven patients received lignocaine 2% with adrenaline in combination with bupivacaine 0.5% with adrenaline to establish epidural anaesthesia. Of these patients, four received additional saline, and three pethidine. One patient from the saline group shivered and none from the pethidine group shivered.
No patient received any premedication, or any intravenous sedative or opioid prior to delivery and observations. Where additional intravenous sedation was used (at the discretion ofthe attending anaesthetist), it was given after the initial period of mother-child bonding.
Nausea occurred in 10 out of 47 patients in the control group (21 %) and in 16 out of 47 of the pethidine group (34%). This difference was not statistically significant (Chi-squared = 1. 91, P = 0.2). None of these patients received any specific treatment for nausea, although one patient who subsequently complained of nausea had been given fentanyl 100 micrograms intravenously, after delivery. This patient came from the treatment (pethidine) group.
Vomiting occurred in none of the control group and four of the pethidine group. A two-tailed Fisher exact test revealed no significant difference between these two groups (P = 0.1). Again, no specific anti-emetic agent was given to any of these patients. None of these patients had received additional sedative or narcotic agent intravenously before or after delivery. As requested, most anaesthetists had avoided the use of supplementary intravenous opioid sedative or antiemetic agents. Drowsiness occurred in 3 out of 47 (6%) of the control group, and 4 out of 47 (8%) of the pethidine group -there was no statistically significant difference between groups -again using a Fisher exact test (P = 1). Only two patients who complained of drowsiness had been given an intravenous sedative agent after deliveryfentanyl 100 micrograms to one patient from the pethidine group, and droperidol 1 mg to one patient from the saline group.
Two patients complained ofpruritis -one each from the saline and pethidine groups.
Apgar scores were compared using Wilcoxon Rank Tests for scores at 1 minute and 5 minutes. There was no significant difference in Apgar scores between groups (P> 0.05 for both groups of scores).
Cord blood was collected and assayed for pethidine in 36 out of 47 treated patients. Eleven samples were inadequately stored. Figure 1 represents neonatal cord blood pethidine levels in micrograms per millilitre against time from injection of pethidine 25 mg into the maternal epidural space. In six cases, no pethidine could be detected. In several cases, a trace « 0.01 micrograms per millilitre) of nor-pethidine was detected.
DISCUSSION
This study has confirmed the value of ep'idural pethidine in the treatment of shivering associated with epidural anaesthesia for caesarean section. To our knowledge, this represents the first attempt to study the effect of low-dose epidural pethidine on shivering associated with epidural anaesthesia for caesarean section. Other investigators have used intravenous pethidine 4 during caesarean section, after delivery, and others epidural fentanyl5 during labour, and sufentanil 6 for elective caesarean section. All have shown a reduction in shivering with treatment. However, it is well known that normal labour is associated with shivering in up to 10% of cases. 7 Thus, studies which examine the effect of agents on shivering associated with epidural anaesthesia for labour may not truly reflect the effect of the opioid on specific epiduralrelated shivering. Use of a population of patients undergoing elective caesarean section eliminates the variable of labour-associated shivering .
The mechanism of shivering associated with epidural anaesthesia in obstetric practice has not yet been determined. Theories include: 1. heat loss secondary to sympathetic blockade and cutaneous vasodilation; 2. differential block of ascending sensory pathways relaying warm and cold information;8
3. the direct effect of cold anaesthetic solutions on therrnosensitive structures within the spinal cord;9 4. a toxic reaction due to intravenous absorption of local anaesthetic agent; 5. the effect of amniotic fluid emboli.
None of these theories has been demonstrated as causal. Indeed, no evidence exists for a reduction in core or peripheral temperature in those patients who shiver subsequent to epidural anaesthesia, nor do these patients usually feel cold. It may be, however, that by suppressing shivering we may unmask a group of patients whose core temperature is reduced with extensive epidural blockade, as suggested by the evidence from the Harvard group. 6 More recently it has been postulated that shivering occurring during epidural anaesthesia may represent a motor disorder due to 'loss of motor control secondary to altered sensory input',1O such as may be unmasked in the patient with subclinical Parkinson's disease. The action of opioids on spinal cord receptors in this context is unclear, although results from animal studies suggest the importance of opioid receptors in the shivering response to cold environment. 1 1 We advocate the use of an opioid via the epidural route rather than the intravenous one. There is evidence that systemic uptake of opioids from the epidural space is similar to that following intramuscular injection.
Brownridge's experience with the use of epidural pethidine during labour in cumulative doses of 25-150 mg, given 0.08-12.1 hours prior to delivery, was shown to be compatible with comfortable mothers and absence of adverse neonatal effects. There was no clear example of neonatal opioid depression in Brownridge's series of 100. 12 Our results for cord blood pethidine concentrations are consistent with those of Brownridge. We found a range of cord blood pethidine concentration between 0-0.07 micrograms per millilitre after pethidine 25 mg epidurally. In Brownridge's series, with cumulative doses of epidural pethidine of up to 150 mg, in several cases combined with intramuscular pethidine, cord blood pethidine concentration ranged from 0.03-0.24 micrograms per millilitre. As in Brownridge's series, no adverse neonatal effects were detected with the use of epidural pethidine, given 20-72 minutes prior to delivery.
A recent literature surveyl3 reveals no known cases of delayed respiratory depression associated with the administration of pethidine via the epidural space. These authors note the 'remarkably safe record' of epidural opioids in the obstetric population. Most work in this area has been done Anaesthesia and Intensive Care, Vol. 19, No. 2, May, 1991 with morphine. However, the pharmacokinetics of pethidine, a more lipophilic agent, suggest an early CSF peak, with a tendency to become fixed to neural tissue.
We feel that epidural pethidine 25 mg is a useful adjunct to epidural anaesthesia for elective caesarean section. It has become common in our institution to administer epidural pethidine 25 mg with the initial local anaesthetic, and a further 25 mg of pethidine given in the recovery room for postoperative analgesia. The patients are subsequently monitored for six hours for signs of respiratory depression or progressive drowsiness. We believe this improves the experience of lower segment caesarean section by reducing the incidence of shivering.
